604 Sinus rhythm maintenance after DC cardioversion of atrial fibrillation, comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform

EP Europace ◽  
2005 ◽  
Vol 7 ◽  
pp. 136-136
2021 ◽  
Vol 10 (7) ◽  
pp. 1456
Author(s):  
Carlo Lavalle ◽  
Michele Magnocavallo ◽  
Martina Straito ◽  
Luca Santini ◽  
Giovanni Battista Forleo ◽  
...  

Transcatheter ablation was increasingly and successfully used to treat symptomatic drug refractory patients affected by supraventricular arrhythmias. Antiarrhythmic drug treatment still plays a major role in patient management, alone or combined with non-pharmacological therapies. Flecainide is an IC antiarrhythmic drug approved in 1984 from the Food and Drug Administration for the suppression of sustained ventricular tachycardia and later for acute cardioversion of atrial fibrillation and for sinus rhythm maintenance. Currently, flecainide is mostly used for sinus rhythm maintenance in atrial fibrillation (AF) patients without structural cardiomyopathy although recent studies enrolling different patient populations have demonstrated a good effectiveness and safety profile. How should we interpret the results of the CAST after the latest evidence? Is it possible to expand the indications of flecainide, and therefore, its use? This review aims to highlight the main characteristics of flecainide, as well as its optimal clinical use, delineating drug indications and contraindications and appropriate monitoring, based on the most recent evidence.


2011 ◽  
Vol 44 (2) ◽  
pp. e11
Author(s):  
Richard Petersson ◽  
Frida Sandberg ◽  
Pyotr Platonov ◽  
Fredrik Holmqvist

2003 ◽  
Vol 8 (3) ◽  
pp. 179-186 ◽  
Author(s):  
Jorge Galperín ◽  
Marcelo V. Elizari ◽  
Pablo A. Chiale ◽  
Remberto Torres Molina ◽  
Raúl Ledesma ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document